IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q1 2025 Holdings

Filed 2025-05-02 | 6 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals, Inc.(ALNY)Common Stock02043Q107$1.2B4,444,44597.2%
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$26.3M3,702,9952.1%
2seventy Bio, Inc.(TSVT*)Common Stock901384107$6.2M1,254,8270.5%
Adverum Biotechnologies, Inc.(AVU0)Common Stock00773U207$790.6K180,9090.1%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$731.0K968,1830.1%
Bluebird Bio, Inc.(BLE0)Common Stock09609G209$102.5K21,0000.0%